Please login to the form below

Not currently logged in

Making savings from European drugs budgets

National programmes of cuts are the order of the day

Is telehealth delivering on its promises?

Using new digital technologies to help patients see their doctors online and not need to attend their surgery can help save time and money - but just how well is

Wearables: the tangible product of the patient revolution

As the relationship between the patient and his doctor evolve, we look at how new technology is playing its part

A patient's eye view of the digital doctor

Doctors, patients and using new technologies and social media to help with a long-term condition

Novo Nordisk becomes diabetes drug sales leader

Novo Nordisk headquartersSupplants former frontrunner Sanofi - but both firms set for a tough 2015


Drivers for change – payer value perceptions

In an ever-changing healthcare environment, the need to prove value for money remains a key focus for payers and reimbursement decision makers.

Patient engagement: the future for outcomes research and clinical trials?

There is growing momentum and recognition among researchers, regulatory agencies, policy makers and payers towards a more patient-centric approach to health outcomes research, including development and validation of Clinical Outcome

Sales reps in the digital age

As the number of doctors willing to see pharmaceutical sales representatives in person declines how digital tools can help with access, reach and rep effectiveness?

Next-generation KOL intelligence

Advances in KOL intelligence are delivering richer insights into clinical landscapes than ever before, better enabling pharma to meet the challenges of an increasingly competitive and complex environment for KOL

Country reports

Is obesity really a problem in Brazil?

Obesity is on the rise in low- and middle-income countries, particularly in urban settings

Turkey: A growing pharma market with huge potential

The Turkish biopharma market offers many opportunities - if it can overcome its sustainability challenge

Creating a 21st century life sciences ecosystem

UK life sciences minister George FreemanThe UK’s life sciences minister on how government and pharma can encourage NHS uptake and innovation


The challenge of antimicrobial resistance

Cubist Patrick-Vink Cubist's Patrick Vink on the company's ambitions in anti-infectives

Switching to a virtual healthcare system

babylon virtual health service Ali Parsa, CEO and founder of babylon, discusses the benefits of conducting healthcare consultations via a smartphone

The role of artificial intelligence in healthcare

Watson on jeopardy IBM's Amer Fasihi on the rise of Watson

White papers

The vitamin D deficiency: should we act?

Healthcare PR agency Say Communications analyses whether headlines are able to trigger a behavioural change with regards to the vitamin D deficiency issue.

Is obesity the new smoking?

Is obesity the new smoking? The healthcare PR team at Say communications analyses the question posed by NHS Chief executive Simon Stevens.

Children, the weight issue and how we deal with this responsibly?

Say Communication, Healthcare PR Agency, looks at how children deal with the weight issue and how we can approach it responsibly.

Longevity but at what price?

Say Communications, healthcare PR agency, analyses the prospect of living to 150 years old, thanks to the anti-ageing biomedical research, and what PR will look like.

Featured jobs

Subscribe to our email news alerts


Add my company
Complete True Life

Complete True Life is a progressive new agency specializing in the validation of insights-led and generation of evidence-based real-world studies...